EP2794627
Setnar kirnisleifar, kirni og hliðstæður þar af
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.12.2012EP published:
26.9.2018EP application number:
12860391.7
EP translation filed:
10.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
19.12.2032Expiry date:
19.12.2022
Title:
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
Timeline
Today
20.12.2012EP application
26.9.2018EP Publication
10.12.2018Translation submitted
15.1.2019Registration published
19.12.2022Expires
Owner
Name:
Janssen BioPharma, Inc.Address:
260-E Grand Avenue, 2nd Floor, 94080, South San Francisco, CA, US
Inventor
Name:
BEIGELMAN, LeonidAddress:
San Mateo, CA, US
Name:
WANG, GuangyiAddress:
Calsbad, CA, US
Name:
SMITH, David, BernardAddress:
San Mateo, CA, US
Name:
DEVAL, JeromeAddress:
Pacifica, CA, US
Name:
PRHAVC, MarijaAddress:
Encinitas, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161579560 PDate:
22.12.2011Country:
US
Number:
201261613836 PDate:
21.3.2012Country:
US
Classification
Categories:
C07H 19/00, C07H 19/06, C07H 19/14, C07H 19/16, A61K 31/4184, A61K 31/522, A61K 31/506, A61K 31/4192, C07D 471/04, C07D 473/34, A61P 31/14, C12N 9/99, A61K 31/675, A61K 31/708, A61K 31/7068, A61K 31/7072
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.11.2018
Expires: 19.12.2019
Payer: Árnason Faktor
Number: 8
Paid: 7.11.2019
Expires: 19.12.2020
Payer: Árnason Faktor
Number: 9
Paid: 6.11.2020
Expires: 19.12.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.11.2021
Expires: 19.12.2022
Payer: Árnason Faktor ehf.